Д. Арчибалд

714 total citations
24 papers, 556 citations indexed

About

Д. Арчибалд is a scholar working on Psychiatry and Mental health, Physiology and Pharmacology. According to data from OpenAlex, Д. Арчибалд has authored 24 papers receiving a total of 556 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Psychiatry and Mental health, 7 papers in Physiology and 3 papers in Pharmacology. Recurrent topics in Д. Арчибалд's work include Schizophrenia research and treatment (8 papers), Asthma and respiratory diseases (4 papers) and Allergic Rhinitis and Sensitization (3 papers). Д. Арчибалд is often cited by papers focused on Schizophrenia research and treatment (8 papers), Asthma and respiratory diseases (4 papers) and Allergic Rhinitis and Sensitization (3 papers). Д. Арчибалд collaborates with scholars based in United States, Belgium and India. Д. Арчибалд's co-authors include William H. Carson, Robert D. McQuade, Elyse Stock, D. Jody, R.N. Marcus, Simon Vanveggel, Felix E. Tristani, Jay N. Cohn, William Jacobs and Gary S. Francis and has published in prestigious journals such as Journal of Allergy and Clinical Immunology, Schizophrenia Research and The Laryngoscope.

In The Last Decade

Д. Арчибалд

24 papers receiving 522 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Д. Арчибалд United States 10 296 125 109 96 61 24 556
Onur N. Karayal United States 12 241 0.8× 56 0.4× 47 0.4× 39 0.4× 19 0.3× 24 452
Ankit Shah United States 12 60 0.2× 161 1.3× 56 0.5× 41 0.4× 17 0.3× 43 669
Kazuhiko Nakayama Japan 8 94 0.3× 131 1.0× 72 0.7× 16 0.2× 9 0.1× 21 335
Yannick Plétan France 13 163 0.6× 40 0.3× 97 0.9× 236 2.5× 27 561
Karin Huizar Sweden 13 234 0.8× 163 1.3× 62 0.6× 162 1.7× 6 0.1× 16 724
Victoria Burtea Romania 11 194 0.7× 29 0.2× 53 0.5× 46 0.5× 22 0.4× 25 478
Panna Sanga United States 10 81 0.3× 147 1.2× 6 0.1× 87 0.9× 16 0.3× 20 353
Ihor W Rak United States 9 265 0.9× 30 0.2× 9 0.1× 63 0.7× 25 0.4× 14 375
Amy Liebeskind United States 5 512 1.7× 52 0.4× 7 0.1× 73 0.8× 33 0.5× 9 678
Chakrapani Balijepalli Germany 11 85 0.3× 54 0.4× 96 0.9× 45 0.5× 13 0.2× 16 470

Countries citing papers authored by Д. Арчибалд

Since Specialization
Citations

This map shows the geographic impact of Д. Арчибалд's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Д. Арчибалд with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Д. Арчибалд more than expected).

Fields of papers citing papers by Д. Арчибалд

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Д. Арчибалд. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Д. Арчибалд. The network helps show where Д. Арчибалд may publish in the future.

Co-authorship network of co-authors of Д. Арчибалд

This figure shows the co-authorship network connecting the top 25 collaborators of Д. Арчибалд. A scholar is included among the top collaborators of Д. Арчибалд based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Д. Арчибалд. Д. Арчибалд is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Laidlaw, Tanya M., Calman Prussin, Reynold A. Panettieri, et al.. (2018). Dexpramipexole depletes blood and tissue eosinophils in nasal polyps with no change in polyp size. The Laryngoscope. 129(2). E61–E66. 77 indexed citations
3.
Prussin, Calman, Tanya M. Laidlaw, Reynold A. Panettieri, et al.. (2017). Dexpramipexole effectively lowers blood and tissue eosinophils in subjects with chronic rhinosinusitis with nasal polyps. Journal of Allergy and Clinical Immunology. 139(2). AB64–AB64. 4 indexed citations
4.
Rudnicki, Stacy A., James D. Berry, Evan W. Ingersoll, et al.. (2012). Dexpramipexole effects on functional decline and survival in subjects with amyotrophic lateral sclerosis in a Phase II study: Subgroup analysis of demographic and clinical characteristics. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration. 14(1). 44–51. 18 indexed citations
5.
6.
Stock, Elyse, Д. Арчибалд, Stavros Tourkodimitris, et al.. (2004). P.2.067 Long-term effects of aripiprazole on affective symptoms of schizophrenia. European Neuropsychopharmacology. 14. S261–S261. 9 indexed citations
7.
Grunze, Heinz, William H. Carson, R. Marcus, et al.. (2004). P.2.072 Aripiprazole treatment for acute mania in patients with bipolar I disorder: A placebo-controlled study. European Neuropsychopharmacology. 14. S264–S264. 1 indexed citations
8.
McQuade, Robert D., et al.. (2004). P.2.061 Long-term weight effects of aripiprazole and olanzapine: Results from a 26-week double-blind comparison study. European Neuropsychopharmacology. 14. S259–S259. 2 indexed citations
9.
Carson, William H., et al.. (2003). Safety and tolerability of aripiprazole in patients with schizophrenia stratified by race. Schizophrenia Research. 60(1). 291–291. 2 indexed citations
10.
Carson, William H., et al.. (2003). Meta-analysis of the efficacy of aripiprazole in schizophrenia. Schizophrenia Research. 60(1). 276–276. 3 indexed citations
11.
Kostić, Dušan, George Manos, Elyse Stock, et al.. (2003). P.2.111 Long-term effects of aripirazole on the negative symptoms of schizophrenia. European Neuropsychopharmacology. 13. S328–S328. 7 indexed citations
12.
Stock, Elyse, William H. Carson, Stephen Kaplita, et al.. (2003). Safety and tolerability meta-analysis of aripiprazole in schizophrenia. Schizophrenia Research. 60(1). 367–367. 4 indexed citations
13.
Арчибалд, Д., George Manos, Stavros Tourkodimitris, et al.. (2003). Reduction in negative symptoms of schizophrenia during long-term therapy with aripiprazole. Schizophrenia Research. 60(1). 271–271. 9 indexed citations
14.
McQuade, Robert D., et al.. (2002). Aripiprazole for long-term maintenance treatment of schizophrenia. European Neuropsychopharmacology. 12. 288–288. 20 indexed citations
15.
Marcus, R., et al.. (2002). Aripiprazole versus placebo in acute mania. European Neuropsychopharmacology. 12. 289–289. 13 indexed citations
16.
Robinson, Donald S., Ronald N. Marcus, Д. Арчибалд, & Sheila Hardy. (1996). Therapeutic dose range of nefazodone in the treatment of major depression.. PubMed. 57 Suppl 2. 6–9. 7 indexed citations
17.
Robinson, Donald S., et al.. (1994). Long-term treatment of depression with nefazodone.. PubMed. 30(2). 165–9. 29 indexed citations
18.
Арчибалд, Д., Max Essex, M. F. McLane, et al.. (1987). Antibodies to HTLV-1 in Saliva of Seropositive Individuals from Japan. Viral Immunology. 1(4). 241–246. 6 indexed citations
19.
Cohn, Jay N., Д. Арчибалд, Gary S. Francis, et al.. (1987). Veterans Administration Cooperative Study on Vasodilator Therapy of Heart Failure: influence of prerandomization variables on the reduction of mortality by treatment with hydralazine and isosorbide dinitrate.. PubMed. 75(5 Pt 2). IV49–54. 80 indexed citations
20.
Арчибалд, Д. & Gerald Shklar. (1985). The effect of calcitonin on experimental osteoradionecrosis in mice.. PubMed. 40(1). 7–12. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Onur N. Karayal Breakdown of academic impact, for papers by Ankit Shah Breakdown of academic impact, for papers by Kazuhiko Nakayama Breakdown of academic impact, for papers by Yannick Plétan Breakdown of academic impact, for papers by Karin Huizar Breakdown of academic impact, for papers by Victoria Burtea Breakdown of academic impact, for papers by Panna Sanga Breakdown of academic impact, for papers by Ihor W Rak Breakdown of academic impact, for papers by Amy Liebeskind Breakdown of academic impact, for papers by Chakrapani Balijepalli
Rankless by CCL
2026